Evidence map›Paper›PMID 41878806›Full record

ArticleBlood2026

Iron overload damages mitochondria and induces metabolic rewiring of hematopoietic stem cells toward glycolysis.

Silvia Sighinolfi, Laura Cassina, Maria Rosa Lidonnici, Stefano Beretta, Davide Stefanoni, Mariangela Storto, Christina Mayerhofer, Trine A Kristiansen, David T Scadden, Ivan Merelli and 3 more

Abstract read
In one paragraph

Article in Blood, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Silvia SighinolfiSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.ORCID 0009-0005-9050-7853
Laura CassinaDivision of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Maria Rosa LidonniciSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-3413-8414
Stefano BerettaSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-4375-004X
Davide StefanoniDivision of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Mariangela StortoSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Christina MayerhoferCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.ORCID 0000-0002-5755-1458
Trine A KristiansenCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.
David T ScaddenCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.ORCID 0000-0001-9821-7133
Ivan MerelliSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-3587-3680
Alessandra BolettaDivision of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Annamaria AprileSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-6019-1345
Giuliana FerrariSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-0790-3133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractIron is an essential element for most cellular processes, and recent evidence highlighted its role in regulating the function of hematopoietic stem cells (HSCs). Abnormal iron levels affect HSC quiescence and self-renewal; however, the mechanism by which iron overload (IO) influences HSC function is still unknown. Here, we show that intracellular IO impairs mitochondrial fitness and bioenergetics, inducing metabolic rewiring. In thalassemic mice, as a model of chronic IO, HSCs accumulate elevated mitochondrial reactive oxygen species (mtROS), low mitochondrial membrane potential, and reduced oxidative phosphorylation. Mitochondrial defects are confirmed in 2 other models of IO, sickle cell disease and iron-loaded wild-type mice, and in vivo iron reduction rescues HSC mitochondria. IO HSCs are highly proliferating and, in the presence of damaged mitochondria, rely on glycolysis for energy production. Notably, restoration of mitochondrial function by targeting in vivo mtROS improved the quiescence and self-renewal of IO HSCs. Our results unravel the critical interplay between iron, ROS, and mitochondrial activity in HSCs, revealing that IO shapes HSC metabolic programs.

Indexed as

GlycolysisHematopoietic Stem CellsIron OverloadMitochondriaAnimalsEnergy MetabolismHumansIronMembrane Potential, MitochondrialMetabolic ReprogrammingMiceOxidative PhosphorylationReactive Oxygen SpeciesIronReactive Oxygen Species

Identifiers

PMID41878806
PMCPMC13389870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.